| [1］Zhang L，Wang F，Wang L，et al.Prevalence of chronic kidney disease in China：a cross sectional survey［J］.Lancet，2012，379：815-822. [2］Hallan SI，Dahl K，Oien CM，et al.Screening strategies for chronic kidney disease in the general population：follow?up of cross sectional health survey［J］.BMJ，2006，333：1047-1052. [3］Zhang L，Zhang P，Wang F，et al.Prevalence and factors associated with CKD：a population study from Beijing［J］.Am J Kidney Dis，2008，51：373-384. [4］袁静，沈燕，查艳.贵阳市老年人群慢性肾脏病流行病学调查［J］.中国老年学杂志，2011，8：1408-1410. [5］胡晓舟，刘章锁，刘东伟，等.郑州市老年人慢性肾脏疾病患病情况及危险因素的初步调查［J］.中华老年医学杂志，2009，28(3)：254-257. [6］孙妍蓓，刘宏，武鸣，等.江苏两个地区老年人群慢性肾脏病的分层随机抽样调查［J］.中华肾脏病杂志，2010，26(11)：812-816. [7］Hsu CY，Ordonez JD，Chertow GM，et al.The risk of acute renal failure in patients with chronic kidney disease［J］.Kidney Int，2008，74：101-107. [8］Coca SG，Cho KC，Hsu CY.Acute kidney injury in the elderly：predisposition to chronic kidney disease and vice versa［J］.Nephron Clin Pract，2011，119：c19-c24. [9］Caudrillier A，Mentaverri1 R，Brazier M.Calciumsensing receptor as a potential modulator of vascular calcification in chronic kidney disease［J］.Nephrology，2010，23(1)：17-22. [10］Speeckaert MM，Vanfraechem C，Speeckaert R，et al.Peroxisome proliferator-activated receptor agonists in a battle against the aging kidney［J］.Ageing Res Rev，2014(14)：1-18. [11］De Santo NG，Perna A，Cirillo M.Low protein diets are mainstay for management of chronic kidney disease［J］.Front Biosci (Schol Ed)，2011，3：1432-1442. [12］Aparicio M，Bellizzi V，Chauveau P，et al，Protein-restricted diets plus keto/amino acids-a valid therapeutic approach for chronic kidney disease patients［J］.J Ren Nutr，2012，22：S1-S22. [13］Gesing AI，Masternak MM，Lewinski A，et al.Decreased levels of proapoptotic factors and increased key regulators of mitochondrial biogenesis constitute new potential beneficial features of long-lived growth hormone receptor gene-disrupted mice［J］.J Gerontol A Biol Sci Med Sci，2013，68(6)：639-651. [14］Kidney Disease：Improving Global Outcomes (KDIGO) CKD Work Group.KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease［J］.Kidney Int Suppl，2013，3：1-150. [15］Gansevoort RT，de Jong PE.Challenges for the present CKD classification system［J］.Curr Opin Nephrol Hypertens，2010，19(3)：308-314. [16］Aronow WS，Fleg JL，Pepine CJ，et al.ACCF/AHA 2011expert consensus document on hypertension in the elderly：a report of the American college of cardiology foundation task force on clinical expert consensus documents developed in collaboration with the American academy of neurology，American geriatrics society，American society for preventive cardiology，Anerican society of hypertension，American society of nephrology，association of black cardiologists，and European society of hypertension［J］.J Am Coll Cardiol，2011，57(20)：2037-2114. [17］Dorresteijn JA，van der Graaf Y，Spiering W，et al.Relation between blood pressure and vascular events and mortality in patients with manifest vascular disease：J-curve revisited［J］.Hypertension，2012，59(1)：14-21. [18］2013 ESH/ESC Guidelines for the Management of Arterial Hypertension［J］.Blood Press，2013，22(4):193-278. [19］黄佑群，刘芳，苟蓉，等.1242例糖尿病肾脏疾病住院患者初诊时情况及危险因素分析［J］.中华肾脏病杂志，2012，28(1)：36-40. [20］Yang W，Lu J，Weng J，et al.Prevalence of diabetes among menand women in China［J］.N Engl J Med，2010，362(12)：1090-1101. [21］Zhuo L，Ren W，Li W，et al.Evaluation of renal biopsis in type 2 diabetic patients with kidney disease：a clinicopathological study of 216 cases［J］.Int Urol Nephrol，2013，45(1)：173-179. [22］Chong YB，Keng TC，Tan LP，et al.Clinical predictors of non-diabetic renal disease and role of renal biopsy in diabetic patients with renal invovement：a single centre review［J］.Ren Fail，2012，34(3)：323-328. [23］Sun YM，Su Y，Li J，et al.Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy ［J］.Biochem Biophys Ｒes Commun，2013，433(4)：359-361. [24］Scheen AJ，Mathieu C.Management of hyperglycaemia in type 2 diabetes：a patient centered approach ［J］.Rev Med Liege，2012，67(12)：623-631. |
